Amanda Feilding, the Founder of The Beckley Foundation, discusses psychedelic research, policy work, and the benefits of psychedelics in a mental health crisis. She advocates for evidence-based drug policies and highlights the neuroplasticity effects of LSD. Amanda shares her journey of scientific and policy work, emphasizing the distinction between psychedelics and other drugs. The podcast delves into cognitive enhancement with psychedelics, research challenges, and the evolving attitudes towards psychedelics globally.

Amanda Feilding, a trailblazing drug policy reformer and founder of the Beckley Foundation, dives deep into the transformative world of psychedelics. She shares fascinating insights from her early experiences with LSD, highlighting its role in understanding consciousness. The conversation explores the stigma surrounding psychedelics and their therapeutic potential, discussing groundbreaking research like psilocybin trials for depression. Amanda emphasizes the urgent need for intelligent drug policy reform and increased accessibility to psychedelic therapies in the face of a mental health crisis.

Neuroscientists discuss the transformative effects of psychedelics on the brain, from exploring consciousness on toad venom to therapeutic potential for treating depression. Pioneers like Amanda Feilding and Robin Carhart-Harris delve into the entropic brain theory and the neuroscience of psychedelics, including serotonin 2A receptors.